RenovoRx, Inc.
RNXTBiotechnology
$1.33−10.74%As of Oct 30vs prior close
- Market cap
- $60M
- P/E (TTM)
- –
- From 52W high
- −47.22%
- EPS (LTM)
- -$0.31
- Revenue (LTM)
- $2M
- Net margin
- -621.71%
- Dividend yield
- 0.00%
Nomior Score
38
Speculative ChargeBottom 26% of the scored universe
Growth69
Quality25
Value36
Momentum58
Resilience33
Growth
+2511.63%revenue a year over 1 fiscal year
YE24 $43KLTM $2M
Connections
Revenue to profitQ2 YE26
The operating loss was 368% of revenue, narrower by 266 pts on a year.
Who owns it
1fund